Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients

Haematologica. 2015 Oct;100(10):e423-7. doi: 10.3324/haematol.2015.129452. Epub 2015 Jul 23.

Authors

Roberto Crocchiolo¹, Luca Castagna², Sylvain Garciaz³, Sabine Fürst³, Jean El Cheikh³, Barbara Sarina², Stefania Bramanti², Angela Granata³, Andrea Vai², Samia Harbi³, Lucio Morabito², Bilal Mohty³, Laura Giordano⁴, Raynier Devillier³, Diane Coso³, Monica Balzarotti², Christian Chabannon³, Carmelo Carlo-Stella², Armando Santoro², Reda Bouabdallah³, Didier Blaise³

Affiliations

¹ Hematology Unit, Humanitas Clinical and Research Center, Rozzano, Italy roberto.crocchiolo@humanitas.it.
² Hematology Unit, Humanitas Clinical and Research Center, Rozzano, Italy.
³ Hematology Department, Institut Paoli-Calmettes, Marseille, France.
⁴ Biostatistic Unit, Humanitas Clinical and Research Center, Rozzano, Italy.

No abstract available

Keywords: efficacy; high-risk; lymphoma; tandem stem cell transplantation.

Publication types

Letter

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Hematopoietic Stem Cell Transplantation* / methods
Humans
Lymphoma / mortality
Lymphoma / pathology
Lymphoma / therapy*
Retreatment
Transplantation, Autologous
Transplantation, Homologous
Treatment Outcome